J Korean Ophthalmol Soc.  2010 Oct;51(10):1354-1367.

A Validation and Reliability Study of the Korean Version of National Eye Institute Visual Function Questionnaire 25

• Heo JW
• Yoon HS
• Shin JP
• Moon SW
• Chin HS
• Kwak HW

Abstract

PURPOSE
To translate and evaluate the reliability and validity of the Korean version of the National Eye Institute Visual Functioning Questionnaire-25 (NEI-VFQ-25).
METHODS
Two bilingual ophthalmologists independently translated the original English version of the NEI-VFQ-25 into written Korean. A panel of the Korean Retina Society reviewed the translations to form a single reconciled forward translation of the Korean version of the NEI-VFQ-25. Another ophthalmologist back-translated this first draft into English. Both the first draft and back-translated draft were edited by a professional translator. To evaluate the correlation and validity, results between the original NEI-VFQ-25 and the Korean version, completed by the bilingual participants, were compared.
RESULTS
The Korean version of the National Eye Institute Visual Functioning Questionnaire-25 was developed by translation, back-translation, and expert supervision. Results from 23 bilingual participants between the original NEI-VFQ-25 and the Korean version were compared and showed statistically significant correlation, with a Spearman's correlation coefficient of 0.4 or greater. The Kolmogorov-Smirnov test results showed no statistically significant differences between the two questionnaires.
CONCLUSIONS
Translation and validation of the Korean version of the NEI-VFQ-25 was achieved.

Keyword

NEI-VFQ-25; Quality of life questionnaire

MeSH Terms

National Eye Institute (U.S.)
Organization and Administration
Surveys and Questionnaires
Reproducibility of Results
Retina
Translations

Reference

References

1. Mangione CM, Phillips RS, Seddon JM, et al. Development of the ‘Activities of Daily Vision Scale'. A measure of visual functional status. Med Care. 1992; 30:1111–26.

2. Steinberg EP, Tielsch JM, Schein OD, et al. The VF-14. An index of functional impairment in patients with cataract. Arch Ophthalmol. 1994; 112:630–8.

3. Ross CK, Stelmack JA, Stelmack TR, et al. Development and sensitivity to visual impairment of the Low Vision Functional Status Evaluation (LVFSE). Optom Vis Sci. 1999; 76:212–20.

4. Wolffsohn JS, Cochrane AL. Design of the low vision qual-ity-of-life questionnaire (LVQOL) and measuring the outcome of low-vision rehabilitation. Am J Ophthalmol. 2000; 130:793–802.

5. Mangione CM, Lee PP, Pitts J, et al. Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ Field Test Investigators. Arch Ophthalmol. 1998; 116:1496–504.

6. Mangione CM, Lee PP, Gutierrez PR, et al. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol. 2001; 119:1050–8.

7. Rossi GC, Milano G, Tinelli C. The Italian version of the 25-item National Eye Institute Visual Function Questionnaire: translation, validity, and reliability. J Glaucoma. 2003; 12:213–20.

8. Toprak AB, Eser E, Guler C, et al. Cross-validation of the Turkish version of the 25-item National Eye Institute Visual Functioning Questionnaire (NEI-VFQ 25). Ophthalmic Epidemiol. 2005; 12:259–69.

9. Suzukamo Y, Oshika T, Yuzawa M, et al. Psychometric properties of the 25-item National Eye Institute Visual Function Questionnaire (NEI VFQ-25), Japanese version. Health Qual Life Outcomes. 2005; 3:65.

10. Chan CW, Wong D, Lam CL, et al. Development of a Chinese version of the National Eye Institute Visual Function Questionnaire (CHI-VFQ-25) as a tool to study patients with eye diseases in Hong Kong. Br J Ophthalmol. 2009; 93:1431–6.

11. Baker RS, Bazargan M, Calderón JL, Hays RD. Psychometric performance of the National Eye Institute visual function questionnaire in Latinos and non-Latinos. Ophthalmology. 2006; 113:1363–71.

12. Labiris G, Katsanos A, Fanariotis M, et al. Psychometric properties of the Greek version of the NEI-VFQ 25. BMC Ophthalmol. 2008; 8:4.

13. Hahm BJ, Shin YW, Shim EJ, et al. Depression and the vision-related quality of life in patients with retinitis pigmentosa. Br J Ophthalmol. 2008; 92:650–4.

14. Seo JH, Yu HG, Lee BJ. Assessment of functional vision score and vision-specific quality of life in individuals with retinitis pigmentosa. Korean J Ophthalmol. 2009; 23:164–8.

15. Klein R, Moss SE, Klein BE, et al. The NEI-VFQ-25 in people with long-term type 1 diabetes mellitus: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Ophthalmol. 2001; 119:733–40.

16. Clemons TE, Chew EY, Bressler SB, et al. National Eye Institute Visual Function Questionnaire in the Age-Related Eye Disease Study (AREDS): AREDS Report No. 10. Arch Ophthalmol. 2003; 121:211–7.

17. Chang TS, Bressler NM, Fine JT, et al. Improved vision-related function after ranibizumab treatment of neovascular age-related macular degeneration: results of a randomized clinical trial. Arch Ophthalmol. 2007; 125:1460–9.

18. Bressler NM, Chang TS, Fine JT, et al. Improved vision-related function after ranibizumab vs photodynamic therapy: a randomized clinical trial. Arch Ophthalmol. 2009; 127:13–21.

19. Suñer IJ, Kokame GT, Yu E, et al. Responsiveness of NEI VFQ-25 to changes in visual acuity in neovascular AMD: validation studies from two phase 3 clinical trials. Invest Ophthalmol Vis Sci. 2009; 50:3629–35.